Research and findings of nutritional values that will increase longevity prospects, prevent and even cure degenerative ocular disease.
April 11 & 12, 2015 - 12 hrs COPE/CEE
9:00 am - 4:00 pm (Saturday 6 hrs, Sunday 6 hrs)
JC Penney Conference Center, Auditorium, North Campus, UMSL
(Lunch and continental breakfast each day)
Program Moderator: Stuart Richer, OD, PhD
|Stuart Richer, OD, PhD
Director, Ocular Preventative Medicine
Lovell Federal Health Care Center
|Paul S. Bernstein, MD, PhD
“Lutein, Zeaxanthin, and Omega-3 Fatty Acids for Ocular Health”
This lecture will cover the basic and clinical science supporting nutritional interventions with carotenoids and lipids against a variety of inherited and acquired retinal disease across the lifespan. I will initially talk about the potential roles of these nutrients in the prevention and treatment of age-related macular degeneration (AMD)with particular focus on the AREDS2 and NAT-2 studies along with a discussion of the current controversies surrounding genetic testing to predict response to nutritional interventions, but there are clearly many more opportunities to intervene with dietary supplements that include these compounds. I will discuss our current studies on macular pigment in infant visual development and the use of carotenoid and lipid supplements for the treatment of Stargardt disease and retinitis pigmentosa, I will conclude with an overview of potential uses of these supplements to enhance visual function in normal individuals.
|Billy Hammond, PhD
“Visual System Assessment 2015”
The latest innovations for measuring visual function including: Ecological Assessment; Visual-Brain Axis; Nutritional Status and Influences.
|Emily Chew, MD
“The Age-Related Eye Disease Study2 (AREDS2) Clinical Updates for Practitioners”
The AREDS2 trial results demonstrate that the addition of omega-3 polyunsaturated fatty acids (PUFAs) had neither beneficial nor harmful effects on the progression to late age-related macular degeneration (AMD). Substituting lutein/zeaxanthin for beta-carotene has an incremental increase in beneficial effects of the AREDS supplement of treatment in persons with intermediate AMD or worse. The clinical trial has also provided important information regarding the observational aspects of the study, including the association of aspirin use and AMD, statins and AMD, and others. The progression of AMD following cataract surgery was also examined. An ancillary study was designed to evaluate the retinal periphery of the AREDS2 participants who had bilateral large drusen or late AMD in one eye at baseline. This was conducted with the use of the OPTOS fundus camera. An important aspect of the AREDS2 study was the genetic evaluation. Studies regarding the use of genetic testing in AMD will also be explored.
|Kimberly Reed, OD
“This is your Eye at a high BMI”
This presentation takes a comprehensive look at the adiposity epidemic among US adults and children. Included will be socioeconomic, neutron-endocrine, hormonal, behavioral, psychological, genetic, and environmental aspects of food and energy regulation. The latest recommendations regarding the “best” protocols for adiposity reduction, including the contribution of exercise, will be discussed. In addition, the literature surrounding food addition, with a specific emphasis on sugar addition, will be critically analyzed.